NCT03399396

Brief Summary

The central goal of this study is to identify the optimal approach to implementing an evidence-based practice facilitation (PF) intervention for the uptake and completion of HPV vaccine among adolescents receiving care in the community, guided by implementation science theory. AIM 1: Determine the clinical effectiveness and cost-effectiveness of two modalities for delivering a multi-component PF intervention to increase HPV vaccination initiation and completion in community-based pediatric practices. The investigators will compare the traditional In-person Coaching PF modality to a lower-resource Web-Based Coaching PF modality. The primary patient outcome is HPV vaccination. The investigators will also examine and compare the sustainability of practice changes on vaccination rates and the effects over time for each intervention modality. AIM 2. Understand mechanisms of why the PF intervention may work better for some pediatric practices than others for HPV vaccination. The investigators will examine theory-based determinants at the organizational, provider, and patient levels that may mediate (explain) or moderate (change) the effects of the PF intervention on vaccination outcomes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
420

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 20, 2017

Completed
27 days until next milestone

First Posted

Study publicly available on registry

January 16, 2018

Completed
1 month until next milestone

Study Start

First participant enrolled

February 21, 2018

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2021

Completed
Last Updated

December 5, 2023

Status Verified

December 1, 2023

Enrollment Period

3 years

First QC Date

December 20, 2017

Last Update Submit

December 3, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Age-appropriate completion rate (ages 13-17)

    Percentage of active patients ages 13-17 who completed the HPV vaccine series before 13th birthday

    Annually, up to 3 years post baseline

Secondary Outcomes (9)

  • Age-appropriate initiation rate (ages 13-17)

    Monthly, up to 36 months post baseline

  • Age-appropriate completion rate (at age 13)

    Monthly, up to 36 months post baseline

  • Age-appropriate initiation rate (at age 13)

    Monthly, up to 36 months post baseline

  • Overall completion rate (ages 13-17)

    Monthly, up to 36 months post baseline

  • Overall initiation rate (ages 13-17)

    Monthly, up to 36 months post baseline

  • +4 more secondary outcomes

Other Outcomes (4)

  • Documented recommendation rate (well visits)

    Monthly, up to 36 months post baseline

  • Documented recommendation rate (all visits)

    Monthly, up to 36 months post baseline

  • Bundling adolescent vaccines rate

    Monthly, up to 36 months post baseline

  • +1 more other outcomes

Study Arms (2)

Web-Based Coaching

EXPERIMENTAL

Web-based delivery of practice facilitation for HPV vaccine

Behavioral: Practice facilitation for HPV vaccine

In-Person Coaching

EXPERIMENTAL

In-person delivery of practice facilitation for HPV vaccine

Behavioral: Practice facilitation for HPV vaccine

Interventions

The practice facilitation intervention provides coaching support to pediatric practices to guide them through quality improvement projects to increase HPV vaccination rates.

In-Person CoachingWeb-Based Coaching

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All providers and staff at each practice

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Vanderbilt University Medical Center

Nashville, Tennessee, 37203, United States

Location

Related Publications (1)

  • Chang RS, Shing JZ, Erves JC, Du L, Koyama T, Deppen S, Rentuza AB, McAfee C, Stroebel C, Cates J, Harnack L, Andrews D, Bramblett R, Hull PC. Measurement of provider fidelity to immunization guidelines: a mixed-methods study on the feasibility of documenting patient refusals of the human papillomavirus vaccine. BMC Med Inform Decis Mak. 2022 Dec 22;22(1):339. doi: 10.1186/s12911-022-02083-2.

MeSH Terms

Interventions

Papillomavirus Vaccines

Intervention Hierarchy (Ancestors)

Viral VaccinesVaccinesBiological ProductsComplex Mixtures

Study Officials

  • Pamela C Hull, PhD

    Vanderbilt University Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Due to the nature of the intervention, it is not possible to blind the practices or study staff to study arm allocation. To minimize bias, allocation will be masked until after baseline data collection of outcome measures, when it is time for each practice to initiate the intervention.
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: Using a two-group, cluster randomized control trial (RCT) design, with the clusters being pediatric practices, practices will be randomized to two study arms representing two delivery modalities of the intervention: In-Person Coaching Arm and Web-Based Coaching Arm. The intervention targets the providers and staff in the pediatric practices to make changes aimed to improve their quality of care, and the study participants are the providers and staff (not patients). Individual patients will not be recruited or enrolled in the study, since the intervention is focused on QI and all patient vaccination outcome data will be collected via aggregated reports from the EHR or other clinical data systems (no individual patient-level private health information (PHI)). The study practices include approximately 190 providers (physicians, nurse practitioners, physician assistants) and 275 other staff (nurses, clinical support staff, administrative staff).
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

December 20, 2017

First Posted

January 16, 2018

Study Start

February 21, 2018

Primary Completion

February 28, 2021

Study Completion

February 28, 2021

Last Updated

December 5, 2023

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will share

Data collected from providers and staff (surveys and interviews) will be made available to other researchers upon request. All individual identifiers will be stripped to ensure confidentiality and privacy of study participants.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
Upon request
Access Criteria
Qualified researcher with IRB approval

Locations